177 related articles for article (PubMed ID: 3908888)
1. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D.
Ikeda R; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1985; 29(10):981-91. PubMed ID: 3908888
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.
Ikeda R; Matsuyama H; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1991; 35(2):125-38. PubMed ID: 1886490
[TBL] [Abstract][Full Text] [Related]
3. The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D.
Bhattacharjee AK; Kwon-Chung KJ; Glaudemans CP
Carbohydr Res; 1979 Aug; 73():183-92. PubMed ID: 113098
[TBL] [Abstract][Full Text] [Related]
4. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.
Spiropulu C; Eppard RA; Otteson E; Kozel TR
Infect Immun; 1989 Oct; 57(10):3240-2. PubMed ID: 2476401
[TBL] [Abstract][Full Text] [Related]
5. Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype A.
Bhattacharjee AK; Kwon-Chung KJ; Glaudemans CP
Carbohydr Res; 1981 Sep; 95(2):237-48. PubMed ID: 7028261
[No Abstract] [Full Text] [Related]
6. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.
Dromer F; Gueho E; Ronin O; Dupont B
J Clin Microbiol; 1993 Feb; 31(2):359-63. PubMed ID: 8432823
[TBL] [Abstract][Full Text] [Related]
7. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
Bacon BE; Cherniak R; Kwon-Chung KJ; Jacobson ES
Carbohydr Res; 1996 Mar; 283():95-110. PubMed ID: 8901265
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.
Eckert TF; Kozel TR
Infect Immun; 1987 Aug; 55(8):1895-9. PubMed ID: 2440810
[TBL] [Abstract][Full Text] [Related]
9. Capsular polysaccharides of Cryptococcus neoformans.
Bhattacharjee AK; Bennett JE; Glaudemans CP
Rev Infect Dis; 1984; 6(5):619-24. PubMed ID: 6209768
[TBL] [Abstract][Full Text] [Related]
10. Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography-mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy.
Cherniak R; Morris LC; Turner SH
Carbohydr Res; 1992 Jan; 223():263-9. PubMed ID: 1596924
[No Abstract] [Full Text] [Related]
11. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.
Cherniak R; Reiss E; Slodki ME; Plattner RD; Blumer SO
Mol Immunol; 1980 Aug; 17(8):1025-32. PubMed ID: 6777664
[No Abstract] [Full Text] [Related]
12. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
Ikeda R; Maeda T
Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387
[TBL] [Abstract][Full Text] [Related]
13. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
[TBL] [Abstract][Full Text] [Related]
14. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.
Dromer F; Salamero J; Contrepois A; Carbon C; Yeni P
Infect Immun; 1987 Mar; 55(3):742-8. PubMed ID: 3546139
[TBL] [Abstract][Full Text] [Related]
15. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.
Ikeda R; Shinoda T; Fukazawa Y; Kaufman L
J Clin Microbiol; 1982 Jul; 16(1):22-9. PubMed ID: 6179964
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
Todaro-Luck F; Reiss E; Cherniak R; Kaufman L
Infect Immun; 1989 Dec; 57(12):3882-7. PubMed ID: 2680986
[TBL] [Abstract][Full Text] [Related]
17. Benzoquinone activation of Cryptococcus neoformans capsular polysaccharide for construction of an immunoaffinity column.
Kozel TR; Hermerath CA
J Immunol Methods; 1988 Feb; 107(1):53-8. PubMed ID: 3125258
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the lipopolysaccharide O antigens of Actinobacillus pleuropneumoniae serotypes 9 and 11: antigenic relationships among serotypes 9, 11, and 1.
Beynon LM; Griffith DW; Richards JC; Perry MB
J Bacteriol; 1992 Aug; 174(16):5324-31. PubMed ID: 1379584
[TBL] [Abstract][Full Text] [Related]
19. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
Turner SH; Cherniak R
Carbohydr Res; 1991 Apr; 211(1):103-16. PubMed ID: 1773425
[TBL] [Abstract][Full Text] [Related]
20. Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.
Small JM; Mitchell TG; Wheat RW
Infect Immun; 1986 Dec; 54(3):735-41. PubMed ID: 3536746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
